期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 22, 期 12, 页码 -出版社
MDPI
DOI: 10.3390/ijms22126535
关键词
discoidin domain receptor (DDR); cancer; kinase inhibitors; structure-activity relationship (SAR); DDR1 and DDR2
资金
- national Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF-2018R1A5A2023127]
DDR is a crucial collagen-activated receptor tyrosine kinase that regulates essential cellular processes, and its dysregulation is associated with various cancers and diseases. Efforts have been made in the development of DDR inhibitors, focusing on the progress of DDR1 and DDR2 inhibitors.
Discoidin domain receptor (DDR) is a collagen-activated receptor tyrosine kinase that plays critical roles in regulating essential cellular processes such as morphogenesis, differentiation, proliferation, adhesion, migration, invasion, and matrix remodeling. As a result, DDR dysregulation has been attributed to a variety of human cancer disorders, for instance, non-small-cell lung carcinoma (NSCLC), ovarian cancer, glioblastoma, and breast cancer, in addition to some inflammatory and neurodegenerative disorders. Since the target identification in the early 1990s to date, a lot of efforts have been devoted to the development of DDR inhibitors. From a medicinal chemistry perspective, we attempted to reveal the progress in the development of the most promising DDR1 and DDR2 small molecule inhibitors covering their design approaches, structure-activity relationship (SAR), biological activity, and selectivity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据